Inside TwoStep: From the Bench to the Term Sheet, and Now, the Clinic

from Stanford Biotech Group Podcast · host Afi

Caitlyn Miller, CEO and co-founder of TwoStep Therapeutics, joins the SBG podcast to discuss her Series A biotech's five-target peptide platform for solid tumors, the path from Stanford PhD to funded company, and what no one tells you about founding.

Episode metadata supplied by the publisher feed · Published May 13, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Inside TwoStep: From the Bench to the Term Sheet, and Now, the Clinic

0:00 22:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Stanford Biotech Group Podcast?

This episode is 22 minutes long.

When was this Stanford Biotech Group Podcast episode published?

This episode was published on May 13, 2026.

Can I download this Stanford Biotech Group Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!